share_log

The 9.7% Return This Week Takes Everjoy Health Group's (SZSE:002162) Shareholders Five-year Gains to 52%

The 9.7% Return This Week Takes Everjoy Health Group's (SZSE:002162) Shareholders Five-year Gains to 52%

本周9.7%的回报率使Everjoy Health Group(深圳证券交易所:002162)股东的五年涨幅达到52%
Simply Wall St ·  2023/10/31 19:25

When we invest, we're generally looking for stocks that outperform the market average. And the truth is, you can make significant gains if you buy good quality businesses at the right price. For example, the Everjoy Health Group Co., Ltd. (SZSE:002162) share price is up 52% in the last 5 years, clearly besting the market return of around 32% (ignoring dividends). However, more recent returns haven't been as impressive as that, with the stock returning just 16% in the last year.

当我们投资时,我们通常会寻找表现优于市场平均水平的股票。事实是,如果你以合适的价格收购质量好的企业,你可以获得巨大的收益。例如,长荣健康集团有限公司。(SZSE:002162)股价在过去5年中上涨了52%,显然超过了约32%的市场回报率(不考虑股息)。然而,最近的回报没有那么令人印象深刻,该股去年的回报率仅为16%。

The past week has proven to be lucrative for Everjoy Health Group investors, so let's see if fundamentals drove the company's five-year performance.

事实证明,过去一周对EverJoy Health Group的投资者来说是有利可图的,所以让我们看看基本面因素是否推动了该公司五年的业绩。

See our latest analysis for Everjoy Health Group

查看我们对EverJoy Health Group的最新分析

Because Everjoy Health Group made a loss in the last twelve months, we think the market is probably more focussed on revenue and revenue growth, at least for now. Generally speaking, companies without profits are expected to grow revenue every year, and at a good clip. That's because fast revenue growth can be easily extrapolated to forecast profits, often of considerable size.

由于EverJoy Health Group在过去12个月中出现亏损,我们认为市场可能更关注收入和收入增长,至少目前是这样。一般来说,没有利润的公司预计每年都会有收入增长,而且增长速度很快。这是因为快速的收入增长可以很容易地推断出预期利润,通常是相当大的规模。

In the last 5 years Everjoy Health Group saw its revenue grow at 4.2% per year. Put simply, that growth rate fails to impress. The modest growth is probably broadly reflected in the share price, which is up 9%, per year over 5 years. We'd be looking for the underlying business to grow revenue a bit faster.

在过去的5年里,长荣健康集团的收入以每年4.2%的速度增长。简而言之,这种增长速度未能给人留下深刻印象。这种温和的增长可能大致反映在股价上,在过去5年中,股价以每年9%的速度上涨。我们希望基础业务能够更快地实现收入增长。

The graphic below depicts how earnings and revenue have changed over time (unveil the exact values by clicking on the image).

下图描述了收益和收入随时间的变化(通过单击图像来揭示确切的价值)。

earnings-and-revenue-growth
SZSE:002162 Earnings and Revenue Growth October 31st 2023
深圳证交所:002162收益和收入增长2023年10月31日

Balance sheet strength is crucial. It might be well worthwhile taking a look at our free report on how its financial position has changed over time.

资产负债表的强健至关重要。也许很值得一看我们的免费报告其财务状况如何随着时间的推移而发生变化。

A Different Perspective

不同的视角

We're pleased to report that Everjoy Health Group shareholders have received a total shareholder return of 16% over one year. That gain is better than the annual TSR over five years, which is 9%. Therefore it seems like sentiment around the company has been positive lately. Someone with an optimistic perspective could view the recent improvement in TSR as indicating that the business itself is getting better with time. It's always interesting to track share price performance over the longer term. But to understand Everjoy Health Group better, we need to consider many other factors. Consider for instance, the ever-present spectre of investment risk. We've identified 1 warning sign with Everjoy Health Group , and understanding them should be part of your investment process.

我们很高兴地报告,EverJoy Health Group的股东在一年内获得了16%的总股东回报。这一收益好于过去五年的年度TSR,后者为9%。因此,最近围绕该公司的情绪似乎一直是积极的。持乐观观点的人可能会认为,最近TSR的改善表明,业务本身正在随着时间的推移而变得更好。跟踪股价的长期表现总是很有趣的。但要更好地了解恒大健康集团,我们还需要考虑许多其他因素。例如,考虑一下无处不在的投资风险幽灵。我们已经确定了1个警告信号与EverJoy Health Group合作,了解他们应该是您投资过程的一部分。

If you like to buy stocks alongside management, then you might just love this free list of companies. (Hint: insiders have been buying them).

如果你喜欢和管理层一起买股票,那么你可能会喜欢这本书免费公司名单。(提示:内部人士一直在买入这些股票)。

Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on Chinese exchanges.

请注意,本文引用的市场回报反映了目前在中国交易所交易的股票的市场加权平均回报。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

对这篇文章有什么反馈吗?担心内容吗? 保持联系直接与我们联系。或者,也可以给编辑组发电子邮件,地址是implywallst.com。
本文由Simply Wall St.撰写,具有概括性。我们仅使用不偏不倚的方法提供基于历史数据和分析师预测的评论,我们的文章并不打算作为财务建议。它不构成买卖任何股票的建议,也没有考虑你的目标或你的财务状况。我们的目标是为您带来由基本面数据驱动的长期重点分析。请注意,我们的分析可能不会将最新的对价格敏感的公司公告或定性材料考虑在内。Simply Wall St.对上述任何一只股票都没有持仓。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发